COMMUNIQUÉS West-GlobeNewswire

-
LifeLabs Celebrates National Medical Laboratory Week Recognizing Compassionate, Passionate, and Innovative Professionals
15/04/2024 -
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
15/04/2024 -
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
15/04/2024 -
Novo Nordisk A/S - share repurchase programme
15/04/2024 -
Sienna Announces April Dividend
15/04/2024 -
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
15/04/2024 -
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
15/04/2024 -
Microbot Medical Shares Status Following Recent Geopolitical Events
15/04/2024 -
Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange
15/04/2024 -
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
15/04/2024 -
The United States FDA Awards Orphan Drug Designation (ODD) to NM5072 for Treating Paroxysmal Nocturnal Hemoglobinuria (PNH)
15/04/2024 -
TOMI Environmental Solutions to Attend Interphex 2024
15/04/2024 -
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
15/04/2024 -
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
15/04/2024 -
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
15/04/2024 -
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
15/04/2024 -
Turning dreams into reality: 1970s-inspired Lachine Hospital Foundation Gala raises $182,830 net to support the modernization and expansion of the Lachine Hospital
15/04/2024 -
Nos rêves deviennent réalité : le gala de la Fondation de l’Hôpital de Lachine, inspiré des années 1970, permet de recueillir 182 830 $ net, pour soutenir la modernisation et l’agrandissement de l’Hôpital de Lachine.
15/04/2024 -
Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole
15/04/2024
Pages